CVS HEALTH CORPORATION Debt Securities, Available-for-sale, Unrealized Loss Position
CVS HEALTH CORPORATION (CVS) had Debt Securities, Available-for-sale, Unrealized Loss Position of $14.82 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $14.82B.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $12.82B.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $6.33B.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $5.44B.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $14.82B 10-Q · filed 2026-08-05 |
| 2026-03-31 | $12.82B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $6.33B 10-Q · filed 2026-08-05 |
| 2025-09-30 | $5.44B 10-Q · filed 2025-10-29 |
| 2025-06-30 | $6.65B 10-Q · filed 2025-07-31 |
| 2025-03-31 | $9.90B 10-Q · filed 2025-05-01 |
| 2024-12-31 | $13.24B 10-K · filed 2026-02-10 |
| 2024-09-30 | $7.46B 10-Q · filed 2024-11-06 |
| 2024-06-30 | $15.00B 10-Q · filed 2024-08-07 |
| 2024-03-31 | $14.24B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $12.55B 10-K · filed 2025-02-12 |
| 2023-09-30 | $18.18B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $17.66B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $16.95B 10-Q · filed 2023-05-03 |
| 2022-12-31 | $18.49B 10-K · filed 2024-02-07 |
| 2022-09-30 | $19.46B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $16.92B 10-Q · filed 2022-08-03 |
| 2022-03-31 | $13.55B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $7.38B 8-K · filed 2023-05-25 |
| 2021-09-30 | $4.39B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $3.07B 10-Q · filed 2021-08-04 |
| 2021-03-31 | $4.59B 10-Q · filed 2021-05-04 |
| 2020-12-31 | $915.00M 10-K · filed 2022-02-09 |
| 2020-09-30 | $2.26B 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.77B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $3.70B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.17B 10-K · filed 2021-02-16 |
| 2019-09-30 | $790.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $600.00M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $2.41B 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |